Navigation Links
NIAID creates HIV vaccine discovery branch
Date:6/25/2008

To accelerate the translation of basic discoveries about HIV into advances in vaccine design and evaluation, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has formed a new Vaccine Discovery Branch within the Vaccine Research Program in the Division of AIDS (DAIDS).

"There is broad scientific consensus that designing a safe and effective vaccine to prevent HIV infection will require enormous advances beyond present-day knowledge," says NIAID Director Anthony S. Fauci, M.D. "The NIAID Vaccine Discovery Branch will help remove fundamental obstacles to achieving this goal by focusing intensively on the development and sharing of new knowledge critical to vaccine development."

The new branch is dedicated to monitoring scientific developments in multiple fields related to HIV vaccine discovery, building more bridges between basic researchers and HIV vaccine designers, identifying gaps in knowledge pertinent to a preventive HIV vaccine and promoting research to fill those gaps.

"Cross-fertilization of HIV/AIDS research with the fields of genetics, structural biology, systems biology and others could open up new perspectives on how to overcome major obstacles to HIV vaccine design," says DAIDS Director Carl W. Dieffenbach, Ph.D. "The Vaccine Discovery Branch will be in an ideal position to spot these opportunities, promote the translation of new knowledge about HIV and foster fruitful research collaborations."

In addition, the new branch will

  • Monitor vaccine discovery efforts and related basic HIV research within NIH, nationally and internationally

  • Determine funding priorities for vaccine discovery research

  • Plan, develop, implement and evaluate extramural grants and contracts to support the conduct of fundamental virology and immunology research as it relates to the discovery of novel AIDS vaccine concepts

  • Foster the development and supply of necessary research reagents and other resources

The Vaccine Discovery Branch also will have chief oversight of the Center for HIV/AIDS Vaccine Immunology (CHAVI), a consortium of universities and academic medical centers established by NIAID to solve major problems in HIV vaccine development and design. A multidisciplinary group of scientists from across DAIDS will continue to participate in overseeing CHAVI.

Jorge Flores, M.D., deputy director of the Vaccine Research Program, will serve as acting chief of the new branch until a national search results in the selection of a new chief. Dr. Flores has been involved in the conduct and administration of vaccine research at NIH since 1979.


'/>"/>

Contact: Laura Sivitz
sivitzl@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Related medicine news :

1. NIAID funds $51M contract to create comprehensive model of immune responses
2. NIAID strengthens and expands Vaccine and Treatment Evaluation Units
3. NIAID scientists identify new cellular receptor for HIV
4. NIAID to convene HIV Vaccine Summit
5. NIAID describes research priorities to fight drug-resistant tuberculosis
6. NIAID to advance B-cell approach to HIV vaccines
7. S.C. BlueCross Creates Corporate Planning Unit, Promotes Davis to Vice President
8. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
9. Exceptional Childrens Foundation Merger with Kayne Eras Center Creates One of States Most Comprehensive Nonprofits Serving the Disabled
10. Prime Access Creates Groundbreaking Ads Targeting Urban Teens for the White Houses National Youth Anti-Drug Media Campaign
11. L.A. Playwright Creates an Enormous Wave with His New Book, Touch the Ocean
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... 23, 2017 , ... PreCheck, Inc., a background screening and ... with a three-year sales growth of 49 percent . The Inc. 5000 is ... comprehensive look at America’s independent entrepreneurs. This represents PreCheck’s fifth consecutive entry on ...
(Date:8/23/2017)... Lauderdale, FL (PRWEB) , ... August 23, 2017 ... ... firms for traveling medical professionals, recently launched a new website, http://www.cirrusmedicalstaffing.com . ... built to respond to the needs of healthcare professionals who are traveling on ...
(Date:8/23/2017)... ... August 23, 2017 , ... Arizona Spine & Joint Hospital ... the designation of High Performing Hospitals by U.S. News & World Report for knee ... was significantly better than the national average in a given procedure or condition.  ...
(Date:8/23/2017)... ... August 23, 2017 , ... Boling Vision Center is excited ... and is now seeing patients at Boling Vision Center’s Elkhart & Notre Dame ... and treatment of eye disease, medical retina, high-technology cataract surgery, cosmetic procedures, and ...
(Date:8/23/2017)... OH (PRWEB) , ... August 23, 2017 , ... ... accessible vans, announced today that has been named to the 2017 Inc. 500|5000, ... 2545 based on a three-year growth rate of 139 percent, marking the twelfth ...
Breaking Medicine News(10 mins):
(Date:8/18/2017)... 2017  Nortis today announced the awarding of a $688K National Institutes of ... year of a Small Business Innovation Research (SBIR)?Fast-track grant under ... Disorders and Stroke (NINDS).?  ... Nortis ParVivo Chip used for 3D ... The neurotherapeutics ...
(Date:8/17/2017)... Aug. 17, 2017 MJAC2017 , the premier ... Broadcast Media, today reveals its leading lineup. ... a global cannabis innovator specializing in the development of pharmaceutical ... conference. MassRoots, Rambridge™ and The Green Organic Dutchman are gold ... Namaste Vapes™ as silver sponsors. ...
(Date:8/17/2017)... 2017 DarioHealth Corp. (NASDAQ: DRIO), a ... and big data solutions, announced today that it ... non-U.S. investors for the sale of shares of ... Company,s newly designated Series B Convertible Preferred Stock ... to conduct a closing with respect to the ...
Breaking Medicine Technology: